º£½ÇÊÓÆµ

Oops.

Our website is temporarily unavailable in your location.

We are working hard to get it back online.

PRIVACY
Manufacturing

India trade agreements ‘great step forward’ for º£½ÇÊÓÆµ in post-Brexit world says pharma boss

Framework between Boris Johnson and Narendra Modi tees up future co-operation that will benefit both nations

Hands Across The Oceans: Boris Johnson and Narendra Modi

The boss of a º£½ÇÊÓÆµ medicine manufacturer said new trading arrangements with India were a big step towards boosting Britain’s overseas presence post-Brexit.

Dr Nik Kotecha OBE, founder and chairman of Morningside Pharmaceuticals in Loughborough, said the Indian market had always been a big part of his business, and he hoped the latest news would help that continue.

He said the framework agreed between Boris Johnson and his Indian counterpart Narendra Modi would tee up future co-operation over the coming years that would benefit both nations.

Following a virtual meeting between the two leaders, No 10 said the “2030 road map” represented a “quantum leap” in the º£½ÇÊÓÆµ-India relationship.

Officials said the wide-ranging document covered co-operation across health, climate change, education, science and technology, and defence.

It also includes a commitment to an “enhanced trade partnership”, paving the way for a full free trade agreement aimed at doubling bilateral trade over the coming decade.

Morningside has licenses to make around 220 different medicines ranging from contraceptives, pain relief and oncology drugs to treatment for conditions such as diabetes, which are sold in the º£½ÇÊÓÆµ and overseas.

It is involved in one of the 20 new export deals signed with India, which are reported to be worth more than £446 million.